|
|||||
|
|
A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109 |
|
| Authors: | Lida A. Mina Menggang Yu Cynthia Johnson Cyndi Burkhardt Kathy D. Miller Robin Zon |
| Affiliation: | 1. Indiana University Melvin and Bren Simon Cancer Center, Indiana Cancer Pavilion, RT-473, 535 Barnhill Dr, Indianapolis, IN, 46202, USA 2. Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA 3. Hoosier Oncology Group, Indianapolis, IN, USA 4. Northern Indiana Cancer Research Consortium, South Bend, IN, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |